| Standard Name | ERG25 |
|---|---|
| Systematic Name | YGR060W |
| Feature Type | ORF, Verified |
| Description | C-4 methyl sterol oxidase, catalyzes the first of three steps required to remove two C-4 methyl groups from an intermediate in ergosterol biosynthesis; mutants accumulate the sterol intermediate 4,4-dimethylzymosterol (1, 2, 3, 4 and see Summary Paragraph) |
| Name Description | ERGosterol biosynthesis |
| Chromosomal Location | |
|---|---|
| View Computational GO annotations for ERG25 | |
| Molecular Function | |
| Manually curated | |
| Biological Process | |
| Manually curated | |
| Cellular Component | |
| Manually curated |
| Pathways |
|---|
| Classical genetics | |
|---|---|
| null | |
| repressible | |
| Large-scale survey | |
| null | |
| reduction of function | |
| repressible | |
| Resources |
| 283 total interaction(s) for 187 unique genes/features. | |
| Physical Interactions |
|
| Genetic Interactions |
|
| Resources |
|
|
| |
| Resources |
| Localization | |
|---|---|
| Phosphorylation | PhosphoGRID | PhosphoPep Database |
| Structure | |
| Homologs |
|
| |||||||||||||
| Last Update | Coordinates: 2011-02-03 | Sequence: 1996-07-31 | ||||||||||||
| Subfeature details |
| ||||||||||||
| Retrieve sequences | |||||||||||||
| S288C only | |
|---|---|
| S288C vs. other species | |
| S288C vs. other strains |
| External Links | All Associated Seq | E.C. | Entrez Gene | Entrez RefSeq Protein | MIPS | Search all NCBI (Entrez) | UniProtKB |
|---|
| Primary SGDID | S000003292 |
|---|
ERG25 encodes C-4 methyl sterol oxidase, which catalyzes the first of three steps required to remove two C-4 methyl groups from an intermediate in ergosterol biosynthesis (3, 4, 1, 2). Cells lacking ERG25 are auxotrophic for ergosterol, and accumulate a methylated sterol interm ediate, 4,4-dimethylzymosterol (3). A combination of mutations in ERG11, which encodes lanosterol 14-alpha-demethylase, and mutations that reduce cellular heme levels (in HEM2 or HEM4) can suppress the erg25 null sterol auxotrophy (5). The hem2 and hem4 mutations also suppress the erg25 phenotype in the presence of an azole antifungal drug (5). Expression of the Candida albicans ERG25 homolog complements the S. cerevisiae erg25 null phenotype (6); a human homolog has also been cloned (7).
| 1) | Lees ND, et al. (1995) Cloning of the late genes in the ergosterol biosynthetic pathway of Saccharomyces cerevisiae--a review. Lipids 30(3):221-6 |
| 2) | Parks LW, et al. (1995) Biochemical and physiological effects of sterol alterations in yeast--a review. Lipids 30(3):227-30 |
| 3) | Bard M, et al. (1996) Cloning and characterization of ERG25, the Saccharomyces cerevisiae gene encoding C-4 sterol methyl oxidase. Proc Natl Acad Sci U S A 93(1):186-90 |
| 4) | Paltauf F, et al. (1992) "Regulation and compartmentalization of lipid synthesis in yeast." Pp. 415-500 in The Molecular and Cellular Biology of the Yeast Saccharomyces: Gene Expression, edited by Jones EW, Pringle JR and Broach JR. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press |
| 5) | Gachotte D, et al. (1997) A yeast sterol auxotroph (erg25) is rescued by addition of azole antifungals and reduced levels of heme. Proc Natl Acad Sci U S A 94(21):11173-8 |
| 6) | Kennedy MA, et al. (2000) Cloning and sequencing of the Candida albicans C-4 sterol methyl oxidase gene (ERG25) and expression of an ERG25 conditional lethal mutation in Saccharomyces cerevisiae. Lipids 35(3):257-62 |
| 7) | Li L and Kaplan J (1996) Characterization of yeast methyl sterol oxidase (ERG25) and identification of a human homologue. J Biol Chem 271(28):16927-33 |





